France 2026: How Employers, HR and the CSE Should Manage Sick Leave, Medical Work‑stoppages and Pre‑return Medical Visits

The sick leave rules France employers must follow in 2026 have changed materially, and failure to adapt exposes organisations to financial penalties, litigation and serious industrial‑relations friction with the Comité Social et Économique (CSE). Recent reforms tighten the rules around medical work stoppages (arrêts maladie), clarify the procedural framework for the pre‑return medical visit (visite de reprise and visite pré‑reprise), and strengthen the CSE’s consultation rights whenever sickness absence triggers collective measures. This guide provides HR directors, general counsel and CSE leaders with a practical, step‑by‑step compliance playbook, complete with checklists, templates and litigation‑risk scenarios, designed to keep operations lawful and workplace relations stable.

For readers who need background on how France’s works‑council requirements operate, that companion article is a useful starting point.

TL;DR, Compliance Checklist: What Employers and the CSE Must Do Now

Before diving into the detail, use this checklist as an immediate action sheet. Every item maps to a legal obligation discussed in the sections that follow.

1. Log every sick certificate within 24 hours of receipt. Employees must forward the arrêt maladie to the employer within 48 hours (CPAM / Service‑public rules). Record the date received, the stated duration and the employee’s department.
2. Transmit the employer’s attestation (attestation de salaire) to the CPAM promptly. Late transmission delays the employee’s daily allowances and can trigger CPAM sanctions against the employer.
3. Calculate and apply the correct waiting period. The statutory three‑day délai de carence applies to CPAM benefits; check whether your collective agreement or company policy waives or reduces it for employer top‑ups.
4. Do not contact the employee about the nature of their illness. Only the occupational health physician (médecin du travail) may assess fitness. HR may communicate about administrative matters and return logistics only.
5. Arrange the pre‑return medical visit (visite de reprise) within eight calendar days of the employee’s return for any absence of 30 days or more due to illness (Code du travail, Article R.4624‑31).
6. Consider a visite pré‑reprise whenever the sick leave exceeds three months, the employee, the treating physician, or the occupational health physician may initiate it (Code du travail, Article R.4624‑29).
7. Inform and consult the CSE before implementing any collective measure linked to mass absences, restructuring tasks, temporary replacements, or changes to working conditions. Failure to consult can void the measure and expose the employer to unfair‑labour‑practice claims.
8. Anonymise all sickness‑absence data shared with the CSE or any internal committee. CNIL guidance prohibits disclosing individual diagnoses or medical details to non‑medical personnel.
9. Update your internal sickness absence policy. Reflect 2026 changes and ensure it is available to all staff, referenced in the règlement intérieur, and reviewed by the CSE.
10. Train line managers on what they can and cannot ask or do during an employee’s absence and upon return.
11. Audit your payroll system for correct CPAM interface coding, waiting‑period calculations and employer top‑up triggers.
12. Document everything. A robust paper trail, from receipt of the certificate to the return‑to‑work meeting minutes, is the best defence in any subsequent litigation.

What Changed in 2026, Quick Legal Summary of Sick Leave Rules France

The 2026 reform package addresses three core areas of concern for employers managing an arrêt maladie in France: the scope and duration of medical work stoppages, the procedural obligations around pre‑return medical visits, and the consequences of non‑compliance.

Key Reforms at a Glance

• Stricter framework for medical work stoppages. The reforms reinforce controls on the issuance and extension of medical work stoppages, introduce enhanced auditing powers for the CPAM and increase penalties for fraudulent or unjustified certificates, affecting both prescribing physicians and, in documented abuse cases, employees.
• Clarified pre‑return medical visit procedures. The timing, triggering events and content of the visite de reprise and visite pré‑reprise are now codified more precisely, with tighter deadlines for employer action.
• Increased employer penalties. Employers who fail to arrange the mandatory pre‑return medical visit, who pressure employees during sick leave, or who bypass CSE consultation before collective absence‑management measures face higher civil damages and potential criminal sanctions.
• Enhanced CSE information rights. The CSE must now receive structured, anonymised reports on sickness absence trends at least once per year, and must be consulted in advance on any policy change affecting absence management.

Key Dates and Timeline

Basics: French Sick Leave, CPAM Compensation and Employer Top‑Ups

Understanding the foundational mechanics of the arrêt maladie in France is essential before addressing the 2026 changes. The system involves three players: the employee, the CPAM (the statutory health‑insurance fund) and the employer.

Who Pays for Sick Leave in France?

Compensation comes from two sources. The CPAM pays indemnités journalières (daily allowances) equal to approximately 50 % of the employee’s daily reference salary, subject to a ceiling. These allowances begin after a three‑day waiting period (délai de carence). On top of this, most employers are required, either by the Code du travail (Article L.1226‑1) or by their applicable collective bargaining agreement (convention collective), to pay a top‑up (complément employeur) that bridges part or all of the gap between the CPAM allowance and the employee’s normal salary. The conditions and duration of this top‑up vary significantly by collective agreement, seniority and the length of the absence.

How Long Can You Go on Sick Leave in France?

There is no single statutory cap. CPAM daily allowances for ordinary illness can be paid for a maximum of 360 days over a rolling three‑year period. For long‑term illness (affection de longue durée, or ALD), benefits may continue for up to three years. During this entire period, the employment contract is suspended, but not terminated, unless specific conditions for dismissal are met. Employers should note that extended absences may, in narrow circumstances, justify dismissal if the prolonged absence genuinely disrupts the operation of the business and a permanent replacement is necessary, but this is strictly controlled by case law and requires careful legal analysis.

Employee Steps and HR Verification

When an employee falls ill, the treating physician issues a medical certificate (avis d’arrêt de travail). The employee must send the first two pages, which contain no diagnostic information, to the CPAM within 48 hours and inform the employer without delay. Employers should verify receipt, confirm the dates, and promptly transmit the attestation de salaire to the CPAM. For employees working remotely from France, additional considerations around the applicable social‑security regime may apply.

Medical Work Stoppages: Employer Rights, Limits and Prohibited Actions

Medical work stoppages, the period during which an employee is certified unfit to work, are at the heart of many employer‑employee disputes. Understanding what employers can lawfully do, and what is strictly prohibited, is critical for managing sick leave rules in France without triggering litigation or collective disputes.

What Employers Can Lawfully Do

• Verify the administrative regularity of the certificate. Check dates, confirm the certificate was received within the required timeframe, and ensure it bears the required stamps.
• Request a counter‑examination (contre‑visite médicale). When the employer pays a top‑up, it is generally entitled to arrange for an independent physician to verify that the employee’s absence is justified. If the employee refuses or the counter‑examination concludes the absence is unjustified, the employer may suspend the top‑up payment.
• Contact the employee about administrative matters, return dates, handover of urgent files, status of ongoing projects, provided the communication is reasonable in frequency and does not amount to pressure to return early.
• Refer the matter to occupational health. If there are concerns about fitness for work or the need for workplace adaptation, the employer may request a visite pré‑reprise through the occupational health service.
• Plan operational continuity. This may include hiring a fixed‑term replacement (CDD de remplacement), redistributing tasks, or, in limited circumstances, restructuring the role, subject to CSE consultation where required.

What Employers Must Not Do

• Never ask about the diagnosis. The employer has no right to know the medical reason for the absence. This information is protected by medical confidentiality and CNIL data‑protection rules.
• Never pressure the employee to return early. Repeated calls, threats of adverse action, or creating a climate of guilt constitute harcèlement moral (moral harassment) under Article L.1152‑1 of the Code du travail.
• Never discipline or dismiss solely because of sickness absence, except in the narrow circumstances permitted by case law (genuine operational disruption + permanent replacement necessity).
• Never bypass the pre‑return medical visit. Allowing an employee to resume work without completing the mandatory visite de reprise exposes the employer to liability for any accident or health deterioration that follows.

Pre‑Return Medical Visit: Procedures and Timing for the Visite de Reprise and Visite Pré‑Reprise

The pre‑return medical visit is one of the most important, and most frequently mishandled, steps in managing sick leave in France. The 2026 reforms have tightened deadlines and clarified responsibilities, making compliance non‑negotiable.

When Is the Visite de Reprise Mandatory?

Under Article R.4624‑31 of the Code du travail, the employer must arrange a return‑to‑work medical examination with the occupational health physician (médecin du travail) within eight calendar days of the employee’s actual return for any absence meeting the following triggers:

• Sick leave of 30 consecutive days or more (non‑occupational illness).
• Any absence due to an occupational illness, regardless of duration.
• Any absence following a workplace accident of 30 days or more.
• Maternity leave (in all cases).

The visit must take place on the day of the actual return or, at the latest, within eight days. The employer arranges and pays for it. The employee cannot be allowed to resume work in a safety‑sensitive role until the occupational health physician has confirmed fitness.

The Visite Pré‑Reprise, Early Planning for Complex Cases

When a sick leave exceeds three months, a visite pré‑reprise may be organised (Code du travail, Article R.4624‑29). Unlike the visite de reprise, this takes place before the employee returns to work and is designed to prepare any necessary workplace adaptations, modified duties, ergonomic equipment, reduced hours, or even reclassification to a different role. It can be initiated by the employee, the treating physician, the CPAM medical adviser, or the occupational health physician. Industry observers expect that the 2026 tightening of procedures will push more employers to use the visite pré‑reprise proactively, rather than waiting for the mandatory visite de reprise.

Step‑by‑Step Procedure and Responsibilities

CSE Obligations and Sick Leave: Consultation, Information Rights and Prevention of Collective Disputes

The CSE plays a central role in monitoring working conditions, and sickness absence management falls squarely within its mandate. Employers who sideline the CSE on these issues risk not only legal sanctions but also escalation into a full‑blown collective dispute, the very scenario the 2026 reforms are designed to prevent.

When Must the CSE Be Consulted?

• Any proposed change to the sickness absence policy or to the règlement intérieur that governs absence management.
• Collective measures triggered by mass absences, task redistribution, overtime mandates, hiring of temporary replacements or organisational restructuring.
• Any proposed disciplinary measure linked to an absence, including dismissal on grounds of operational disruption caused by prolonged sick leave.
• Annual review of sickness absence data, the employer must now present anonymised, aggregated data on absence trends to the CSE at least once a year as part of the bilan social or equivalent report.

Red Flags That Escalate to Collective Dispute Risk

• Repeated failure to consult the CSE before implementing absence‑related changes.
• Denial of CSE access to anonymised absence statistics.
• Systematic use of counter‑examinations perceived as punitive rather than legitimate.
• Manager‑level conduct that amounts to pressure on sick employees to return, reported to the CSE by staff.
• Unilateral modification of top‑up conditions without collective bargaining or CSE consultation.

For a deeper analysis of the CSE’s procedural rights and the mechanics of mandatory consultation, see our guide on France works‑council requirements.

Template: CSE Meeting Agenda, Sickness Absence Review

Sample, adapt to company policy and collective agreement; obtain local counsel sign‑off before use.

1. Presentation of anonymised absence data (preceding 12 months): frequency, duration, departmental breakdown.
2. Identification of trends and root causes (workload, working conditions, psychosocial risks).
3. Review of any proposed policy changes or collective measures in response.
4. CSE observations, questions and counter‑proposals.
5. Action plan with timelines and assigned responsibilities.
6. Date of next follow‑up review.

HR Process: Documentation, Return‑to‑Work Meetings and Templates for Gestion Arrêts Maladie

Robust documentation is the employer’s best defence in any subsequent dispute. Every stage of the sick‑leave and return‑to‑work cycle should generate a written record. Here is the core process, along with ready‑to‑adapt templates.

Recordkeeping Checklist

• Date and time the sick certificate was received.
• Copy of the attestation de salaire sent to the CPAM, with proof of transmission.
• Any communications with the employee during the absence (administrative only, never medical content).
• Counter‑examination request and results (if applicable).
• Scheduling confirmation for the visite de reprise or visite pré‑reprise.
• Occupational health physician’s fitness certificate (avis d’aptitude or avis d’inaptitude).
• Return‑to‑work meeting minutes.
• Any adaptations implemented following occupational health recommendations.
• CSE consultation minutes (where applicable).

Template: Pre‑Return Visit Notification Letter

Sample, adapt to company policy and collective agreement; obtain local counsel sign‑off before use. Filename: TEMPLATE_Pre-Return-Visit-Notice_FR.docx

[Company Letterhead]
Date: [Date]
To: [Employee Name]
Subject: Scheduling of your visite de reprise

Dear [Employee Name],

Following your notification that you intend to return to work on [date], we have scheduled your mandatory return‑to‑work medical visit with the occupational health service on [date] at [time] at [location/address].

This visit is required under the Code du travail and must take place before or within eight calendar days of your return. Please confirm your attendance or contact [HR contact] if you need to reschedule.

We look forward to welcoming you back.

[Signature, HR Director / Manager]

Template: Return‑to‑Work Meeting Agenda

Sample, adapt to company policy; obtain local counsel sign‑off before use. Filename: TEMPLATE_Return-to-Work-Meeting_FR.docx

1. Welcome and confirmation of return date.
2. Review of occupational health physician’s recommendations (adaptations, reduced hours, equipment).
3. Update on any changes to the team, reporting lines, or projects during the absence.
4. Discussion of any support the employee may need (training refresh, workload ramp‑up plan).
5. Confirmation of next steps and follow‑up meeting date.
6. Employee’s questions and any concerns raised.
7. Minutes signed by both parties.

CNIL Compliance: Handling Medical Data

CNIL guidance makes clear that employers must treat all health‑related data with the highest level of protection. HR files should never contain diagnostic information. The sick certificate forwarded to the employer must not include medical details (the diagnostic section is reserved for the CPAM only). Any sickness absence data shared internally, with the CSE, with managers, or in reports, must be anonymised and aggregated. Breaches can result in CNIL sanctions and civil liability.

Enforcement Risks and Litigation Scenarios, Five Case Studies

These scenarios illustrate the most common pitfalls employers face when managing medical work stoppages and pre‑return medical visits under the updated sick leave rules in France.

• Scenario 1: Failure to consult the CSE before task redistribution. An employer redistributes a long‑absent employee’s workload across the team without informing or consulting the CSE. Risk: The CSE can challenge the measure before the tribunal judiciaire, seek an injunction to suspend the redistribution, and claim damages. Mitigation: Always schedule a CSE information‑and‑consultation meeting before implementing any collective measure linked to absence.
• Scenario 2: Manager pressures employee to return early. A line manager calls a sick employee multiple times, questioning the legitimacy of the absence and hinting at adverse career consequences. Risk: This constitutes harcèlement moral (Article L.1152‑1, Code du travail). The employee may seek damages and the employer may face criminal prosecution. Mitigation: Train managers on permissible communications and centralise all absence‑related contact through HR.
• Scenario 3: No visite de reprise arranged. An employee returns after 45 days of sick leave and resumes work immediately. No medical visit is scheduled. Two weeks later, the employee suffers a relapse. Risk: The employer bears full liability for failing to fulfil its safety obligation (obligation de sécurité). The relapse may be reclassified as an occupational illness, with all associated costs. Mitigation: Automate scheduling triggers so that any absence of 30 days or more flags an immediate visite de reprise requirement.
• Scenario 4: Medical data shared with management. HR forwards the occupational health physician’s detailed report, including diagnostic references, to the department head. Risk: CNIL sanctions and civil liability for breach of medical confidentiality. Mitigation: Share only the physician’s conclusion (fit / unfit / fit with adaptations) and the specific adaptations required. Never share diagnostic content.
• Scenario 5: Dismissal during sick leave without proper grounds. An employer dismisses an employee on long‑term sick leave citing “operational disruption” without demonstrating genuine, concrete disruption or the necessity of a permanent replacement. Risk: The dismissal will be deemed sans cause réelle et sérieuse (without real and serious cause), entitling the employee to substantial damages under the Macron scale (barème Macron). Mitigation: Document the operational disruption in detail, demonstrate that a permanent replacement is required, and take legal advice before initiating any dismissal procedure.

Sick Leave Obligations in France, Comparison Table

Conclusion, Quick Action Plan for the Next 30, 90 and 180 Days

The 2026 changes to the sick leave rules France employers must follow are not optional refinements, they are enforceable obligations with real financial and operational consequences. Here is a condensed action plan to drive compliance and prevent collective disputes.

• Within 30 days: Audit your current sickness absence policy against the 2026 reforms. Identify gaps. Brief all HR staff and line managers on the updated rules. Schedule the required CSE information session if one has not taken place in the current year.
• Within 90 days: Update your règlement intérieur and internal sickness absence policy. Submit the revised policy to the CSE for consultation. Implement automated triggers in your HR system for visite de reprise scheduling (30‑day threshold) and visite pré‑reprise reminders (three‑month threshold). Review CNIL compliance for all health‑data processing.
• Within 180 days: Conduct a full review of sickness absence trends with the CSE. Evaluate whether your collective agreement top‑up provisions need renegotiation. Run a tabletop exercise on one of the litigation scenarios above to test your organisation’s readiness. Document lessons learned and feed them into the next policy review cycle.

Employers and CSE leaders navigating these changes, particularly those managing complex cases involving cross‑border employees subject to France’s 2026 language and immigration requirements, should seek specialist labour‑law guidance early. The cost of prevention is always lower than the cost of litigation. A searchable directory of qualified labour lawyers practising in France is available through the Global Law Experts lawyer directory.

Sources

1. Service‑public, Official guidance on sick leave (arrêt maladie)
2. Ameli, Assurance Maladie (CPAM) official guidance
3. Legifrance, Code du travail
4. Ministère du Travail, Travail‑Emploi official guidance
5. Journal Officiel / Legifrance, Published laws and decrees
6. CNIL, Guidance on processing health data at work
7. INRS, Occupational health and safety guidance